N 5984

Drug Profile

N 5984

Alternative Names: KRP-204; N-5984

Latest Information Update: 08 Feb 2010

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Nisshin Pharma
  • Developer Kyorin Pharmaceutical; Nisshin Pharma
  • Class Antihyperglycaemics; Carboxylic acids; Dioxins; Obesity therapies; Small molecules
  • Mechanism of Action Beta 3 adrenergic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diabetes mellitus; Obesity; Overactive bladder

Most Recent Events

  • 26 Sep 2007 Nisshin Pharma and Kyorin Pharmaceutical pass a resolution to dissolve the Nisshin-Kyorin joint venture
  • 15 May 2006 No development reported - Phase-II for Diabetes mellitus in Japan (PO)
  • 15 May 2006 Phase-II clinical trials in Obesity (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top